Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Short-term Investments: 2009-2018

Historic Short-term Investments for Lifecore Biomedical (LFCR) over the last 6 years, with May 2018 value amounting to $1.5 million.

  • Lifecore Biomedical's Short-term Investments rose 66.34% to $1.5 million in Q4 2018 from the same period last year, while for Nov 2018 it was $1.5 million, marking a year-over-year increase of 66.34%. This contributed to the annual value of $1.5 million for FY2018, which is 122.24% up from last year.
  • As of FY2018, Lifecore Biomedical's Short-term Investments stood at $1.5 million, which was up 122.24% from $688,000 recorded in FY2017.
  • Lifecore Biomedical's Short-term Investments' 5-year high stood at $1.5 million during FY2018, with a 5-year trough of $688,000 in FY2017.
  • For the 2-year period, Lifecore Biomedical's Short-term Investments averaged around $1.1 million, with its median value being $1.1 million (2017).
  • Data for Lifecore Biomedical's Short-term Investments shows a peak YoY spiked of 122.24% (in 2018) over the last 5 years.
  • Over the past 2 years, Lifecore Biomedical's Short-term Investments (Yearly) stood at $688,000 in 2017, then skyrocketed by 122.24% to $1.5 million in 2018.